Salvage high dose rate brachytherapy after primary external beam irradiation in localized prostate cancer

A case report

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

No standard treatment exists for locally relapsed prostate cancer after primary external beam radiotherapy with no evidence of distant metastases. Radical prostatectomy, brachytherapy, cryotherapy and high-intensity focused ultrasound are currently used as local salvage treatments. Data on the safety and effectiveness of high dose rate (HDR) brachytherapy in this scenario are limited. We report on a patient who has no evidence of disease and no late urinary or gastrointestinal toxicity 33 months after receiving HDR treatment for recurrent prostate cancer.

Original languageEnglish
Pages (from-to)553-556
Number of pages4
JournalTumori
Volume95
Issue number4
Publication statusPublished - 2009

Fingerprint

Brachytherapy
Prostatic Neoplasms
Salvage Therapy
Cryotherapy
Prostatectomy
Radiotherapy
Neoplasm Metastasis
Safety
Therapeutics

Keywords

  • HDR brachytherapy
  • Prostate cancer
  • Reirradiation
  • Salvage therapy

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

@article{600c3e04d0af49adbda3768ccef8be45,
title = "Salvage high dose rate brachytherapy after primary external beam irradiation in localized prostate cancer: A case report",
abstract = "No standard treatment exists for locally relapsed prostate cancer after primary external beam radiotherapy with no evidence of distant metastases. Radical prostatectomy, brachytherapy, cryotherapy and high-intensity focused ultrasound are currently used as local salvage treatments. Data on the safety and effectiveness of high dose rate (HDR) brachytherapy in this scenario are limited. We report on a patient who has no evidence of disease and no late urinary or gastrointestinal toxicity 33 months after receiving HDR treatment for recurrent prostate cancer.",
keywords = "HDR brachytherapy, Prostate cancer, Reirradiation, Salvage therapy",
author = "{De Cicco}, Luigi and Andrea Vavassori and Federica Cattani and Jereczek-Fossa, {Barbara A.} and Roberto Orecchia",
year = "2009",
language = "English",
volume = "95",
pages = "553--556",
journal = "Tumori",
issn = "0300-8916",
publisher = "SAGE Publications Ltd",
number = "4",

}

TY - JOUR

T1 - Salvage high dose rate brachytherapy after primary external beam irradiation in localized prostate cancer

T2 - A case report

AU - De Cicco, Luigi

AU - Vavassori, Andrea

AU - Cattani, Federica

AU - Jereczek-Fossa, Barbara A.

AU - Orecchia, Roberto

PY - 2009

Y1 - 2009

N2 - No standard treatment exists for locally relapsed prostate cancer after primary external beam radiotherapy with no evidence of distant metastases. Radical prostatectomy, brachytherapy, cryotherapy and high-intensity focused ultrasound are currently used as local salvage treatments. Data on the safety and effectiveness of high dose rate (HDR) brachytherapy in this scenario are limited. We report on a patient who has no evidence of disease and no late urinary or gastrointestinal toxicity 33 months after receiving HDR treatment for recurrent prostate cancer.

AB - No standard treatment exists for locally relapsed prostate cancer after primary external beam radiotherapy with no evidence of distant metastases. Radical prostatectomy, brachytherapy, cryotherapy and high-intensity focused ultrasound are currently used as local salvage treatments. Data on the safety and effectiveness of high dose rate (HDR) brachytherapy in this scenario are limited. We report on a patient who has no evidence of disease and no late urinary or gastrointestinal toxicity 33 months after receiving HDR treatment for recurrent prostate cancer.

KW - HDR brachytherapy

KW - Prostate cancer

KW - Reirradiation

KW - Salvage therapy

UR - http://www.scopus.com/inward/record.url?scp=70350065503&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350065503&partnerID=8YFLogxK

M3 - Article

VL - 95

SP - 553

EP - 556

JO - Tumori

JF - Tumori

SN - 0300-8916

IS - 4

ER -